Global Pharmaceuticals & Biotech Undervalued over 20% based on DCF

Eli Lilly

Market Cap: US$1.1t

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.

Johnson & Johnson

Market Cap: US$634.1b

Engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide.

AbbVie

Market Cap: US$446.5b

A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.

Merck

Market Cap: US$311.2b

Operates as a healthcare company worldwide.

AstraZeneca

Market Cap: UK£207.1b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

Amgen

Market Cap: US$198.6b

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.

Danaher

Market Cap: US$135.0b

Designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.

Vertex Pharmaceuticals

Market Cap: US$126.5b

Operates as a biotechnology company in the United States, Europe, and internationally.

Chugai Pharmaceutical

Market Cap: JP¥12.1t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

Jiangsu Hengrui PharmaceuticalsLtd

Market Cap: CN¥366.9b

A pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally.

WuXi AppTec

Market Cap: CN¥364.2b

An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.

Galderma Group

Market Cap: CHF 40.9b

Operates as a dermatology company worldwide.

Haleon

Market Cap: UK£31.8b

Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

CSL

Market Cap: AU$60.1b

Engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.

Natera

Market Cap: US$39.3b

A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.

Teva Pharmaceutical Industries

Market Cap: US$38.7b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

Sandoz Group

Market Cap: CHF 29.7b

Develops, manufactures, and markets generic and biosimilars worldwide.

Agilent Technologies

Market Cap: US$36.5b

Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.

Otsuka Holdings

Market Cap: JP¥5.8t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

IQVIA Holdings

Market Cap: US$34.0b

Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.

Daiichi Sankyo Company

Market Cap: JP¥4.9t

Manufactures and sells pharmaceutical products in Japan and internationally.

Illumina

Market Cap: US$28.4b

Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

Hansoh Pharmaceutical Group

Market Cap: HK$188.9b

An investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China.

Innovent Biologics

Market Cap: HK$150.1b

A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.

PharmaEssentia

Market Cap: NT$529.7b

A biopharmaceutical company engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API, and new drug patterns developments in the Americas, Europe, Asia, and Taiwan.

Ipsen

Market Cap: €13.9b

A biopharmaceutical company, develops and commercializes medicines in the areas of oncology, rare disease, and neuroscience in North America, Europe, and internationally.

Shionogi

Market Cap: JP¥2.4t

Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.

Eurofins Scientific

Market Cap: €12.0b

Provides various analytical testing and laboratory services worldwide.

ICON

Market Cap: US$12.7b

A clinical research organization, provides outsourced development and commercialization services in Ireland, Europe, the United States, and internationally.

Elanco Animal Health

Market Cap: US$12.3b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

Revvity

Market Cap: US$12.2b

Provides health sciences solutions, technologies, and services.

Recordati Industria Chimica e Farmaceutica

Market Cap: €10.4b

Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.

Akeso

Market Cap: HK$87.2b

A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.

ALTEOGEN

Market Cap: ₩16.1t

A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.

Tempus AI

Market Cap: US$10.3b

Operates as a healthcare technology company in the United States.

Zhangzhou Pientzehuang Pharmaceutical

Market Cap: CN¥66.6b

Manufactures and distributes pharmaceuticals and cosmetics in China and internationally.